D. Ross Camidge
banner
drcamidge.bsky.social
D. Ross Camidge
@drcamidge.bsky.social
Oncologist, writer, award-winning ‘How This is Building Me’ Onclive podcast host - fan of truth, creativity and humor
https://podcasts.apple.com/us/podcast/how-this-is-building-me/id1726421043
Pinned
Every year since 2018 we have gathered 5 or more year survivors of lung cancer together at CU to show others that hope has a face. This is the May 11th 2024 gathering. Rock on!
Started as a general oncologist and ended up a specialist- the opposite way of most. Later the pathway king, guiding behavior and prescribing nationally.
November 23, 2025 at 9:59 PM
Mark Socinski grew up in Norman Rockwell land. Rural Vermont, choir boy, stone and marble family business
November 23, 2025 at 9:59 PM
podcasts.apple.com/us/podcast/h... Recently live: Me and Socinski
podcasts.apple.com
November 23, 2025 at 9:59 PM
His insights into the true tale of society and disfigurement, of parenting or mentorship, of owning our creative efforts hidden in Mary Shelley’s classic are as much in everyday life as they are in my medical perspective.
November 19, 2025 at 6:45 PM
@realgdt.bsky.social This weekend I watched the new Frankenstein movie. What a delight to see the true message presented. In 2007 the British Medical Journal commissioned me to review Frankenstein as a classic medical text. I hope GDT appreciates all his praise.
November 19, 2025 at 6:45 PM
nam02.safelinks.protection.outlook.com?url=https%3A... A little chat with the ALK positive lung cancer community post my own diagnosis
Living on Both Sides of Lung Cancer
Dr. Ross Camidge, Director of Thoracic Oncology at the Colorado Cancer Center, has been a trusted voice and sought-after second opinion for lung cancer patients around the world for decades. He has spoken at ALK Positive Summits, appeared on ALKtALK, and serves on the ALK Positive Scientific Advisory Board — guiding and supporting our community. However, for the past three years, this beloved key opinion leader, researcher, and advocate has been quietly facing his own stage IV lung cancer diagnosis. Dr. Camidge returns to ALKtALK, this time not only as an expert in thoracic oncology, but as a patient himself. This honest and deeply human conversation, recorded during Lung Cancer Awareness Month, is a chance to learn from someone who lives this life from both sides of the stethoscope. Whether you're newly diagnosed, in active treatment, or supporting someone you love, we hope you find this discussion informative, inspiring, and empowering. It's a story that reminds us how knowledge, compassion, and resilience connect us all. This ALKtALK event was originally held live on Sunday, November 9th and included a Q&A session. We are pleased to share the full recording here for anyone who couldn’t join us live. If you find this conversation helpful, please like the video, share your thoughts in the comments, and subscribe to the ALK Positive YouTube channel for future ALKtALKs and community updates. #ALKpositive #LivingWithLungCancer #EGFR #LungCancerAwareness #MoreResearchMoreTime + + + About our ALKtALKs and ALK Positive Inc + + + ALK Positive does not endorse specific treatments and does not provide medical advice. Questions and concerns should be raised with individual care teams. ALK Positive is a 501(c)(3)-registered, patient-driven organization that seeks a cure for ALK+ cancer and works to improve patients’ quality of life and life expectancy worldwide. ALK Positive is committed to raising funds for research proposals that will transform ALK-positive cancer into a chronic or curable condition for all patients living with this disease. We offer a full range of Healing Arts classes to help our community balance a productive life, treatment side effects and the mental stress of a cancer diagnosis. These include ALKtALKs -- our flagship community program aimed at making our ALK community a little smarter and a little smaller, by bringing the latest information, research and practices from leading experts. For more information about us, go to www.alkpositive.org. To donate 💖 go to https://www.alkpositive.org/ways-to-give 📢 Follow us on social media & join the conversation online! Facebook 📘 / alkpositivecancer Instagram 📸 / alkpositiveinc LinkedIn 💼 / alkpositivecancer X (Twitter) ✖️ https://x.com/ALKPositiveinc TikTok 🎵 / alkpositiveinc BlueSky ☁️ https://bsky.app/profile/alkpositive....
nam02.safelinks.protection.outlook.com
November 18, 2025 at 2:10 AM
It becomes a footnote in their life. It doesn’t take long before you just think here comes Doug and that’s the best thing in your day.
November 16, 2025 at 3:48 PM
You can hear doug coming as he vocalizes with puffs and grunts all the time. You can see him coming as his arms and head and shoulders twitch and spasm all the time. But, just like any diagnosis, once you know the person their headline grabbing diagnosis fades.
November 16, 2025 at 3:48 PM
Doug Ney is many things. A neurologist, an oncologist who specializes in brain cancers, one of the kindest and most patient people I know and, as a footnote in his life once you get to know him, someone affected by Tourette’s Syndrome. The real kind not the TV version shorthand for swearing a lot
November 16, 2025 at 3:48 PM
For those of you who haven’t figured this out yet. The files come out about a year after the broadcast. The immediate release get some chat from me to but they are more first impressions than reflections.
November 16, 2025 at 3:48 PM
Yes like a safari park for adoptable cats
November 14, 2025 at 1:39 PM
My friend julie is my trainer and an award winning wildlife photographer. What happens when a photographer gets breast cancer and a double mastectomy two weeks ago? This…
November 9, 2025 at 10:35 PM
Another day, another chess match in a cat cafe. This time against the legendary wildlife photographer and former chess club nerd, Julie Price. She bragged about crushing me in every one of our prior matches but with kitty distractions in place the tables were turned today. Oh yeah!
November 9, 2025 at 8:31 PM
Me and my oldest daughter (16 next week) playing chess in Denver’s cat cafe today. Our favorite from this morning was Mr black n white, but luckily we escaped unburdened by another animal to look after
November 8, 2025 at 11:18 PM
My very own ‘f you cancer’ t-shirt courtesy of Stacy Stoutenberg in clinic this week. The club that no one wants to be a member of actually has really fun members once you’re in it!
November 7, 2025 at 6:44 PM
First day of CU’s ‘B fit B well’ exercise program for cancer patients. Waiting to meet the trainers
November 6, 2025 at 10:59 PM
Finally we have to draw distinction between association and causation- liver Mets aren’t the promise that death is coming. There are multiple individual exceptions to associating A with B. The research starts here it doesn’t end here
November 1, 2025 at 11:48 PM
Do we need liver vs non liver progression endpoints in trials? This is assessable now in retrospect. Do we need to look at biopsies from liver vs other sites
November 1, 2025 at 11:48 PM
Is the liver just a manifestation of non drug level related resistance- ie biological change. Would it be the same with any other site of extracranial disease or is the liver something different? That is still to be determined and if it is different then, like the brain, we need to look more
November 1, 2025 at 11:48 PM
The brain story reflects improved attention paid to the cns in drug selection and trial design addressing the elephant in the room of drug penetration into brain (plus some new breakthroughs coming).
November 1, 2025 at 11:48 PM
The takeaways from the paper are that liver metastases more than brain metastases are predictors of worse outcome in ALK and ros1. But there are other messages
November 1, 2025 at 11:48 PM
This is a mirror image of an article i wrote with jose pacheco on characteristics of ALK longterm survivors www.jtocrr.org/article/S266...
Characteristics of Short-Term Survivors With ALK or ROS1-Altered Metastatic NSCLC
The prognostic significance of baseline and on-treatment brain and liver metastasis in ALK+ or ROS1+ metastatic NSCLC (mNSCLC) remains unclear. As we consider intensification strategies, it is critica...
www.jtocrr.org
November 1, 2025 at 11:48 PM
Visiting family 🤦‍♂️
November 1, 2025 at 12:00 AM
Happy Halloween from The Oncologist’s Garden
October 31, 2025 at 11:18 PM